IAS News and Literature Updates:
September and October 2019

         In Memoriam        

Dr. Shaukat Sadikot 1950-2019
It is with deep sadness and regret that the International Atheroscleroisi Society (IAS) announces the passing of its former Board member, Dr. Shaukat Sadikot, on October 1, 2019.
Dr. Sadikot, from India, was closely assoiciated with the activities of IAS for many years and was chair of DiabetesIndia, one of the IAS 67 member societies. A true icon of the diabetes world, Dr. Sadikot was actively involved with the cause of diatetes and associated metabolic disorders in India, regionally and internatinally for over 30 years. He was elected to the role of President-Elect of the International Diabetes Federation (IDF) in 2013 and subsequently served as President of IDF for the period 2016-2017. He worked as a Consultant in Endocrinology at the Jaslok Hospital and Research Center, Mumbai ans served as President of DiabetesIndia for many years. Dr. Sadikot was instrumental in conducting the first nationwide survey on the prevalence of diabetes in India. In his capacity as Founding President of DiabetesIndia, he launched many projects for the enhancement of healthcare professional education in the field of diabetes. Dr. Sadikot was also editor of the international scientific journal "Diabetes and the Metaboic Syndrome: Clinical Research and Reviews", and author of four books and over 90 publications. DiabetesIndial published "Sadikot's International Textbook of Diabetes," which included contributions from more than 100 authors.

IAS extends its deepest condolences to Dr. Sadikot's family and friends in this time of grief.

            IAS ACTIVITIES         
In relation to the 1st Wael Al-Mahmeed & IAS Research Training Grants and Fellowships for the MENA Region project, we are pleased to inform you that after the selection from the Review Committee, I am honored to announce the winners of these prestigious Fellowships:

Muna Al-Balushi
Sultan Qaboos University
Muscat, Oman


Amany Chahine
Department of Biology Murr Building
University of Balamand, Koura
Tripoli, Lebanon


Ganjali Shiva
PhD Candidate of Medical Biotechnology
Faculty of Medicine Mashhad University of Medical Sciences
Mashhad, Iran

This high-level initiative has been made possible thanks to a generous donation kindly offered by Dr. Wael Abdulrahman Al Mahmeed (Abu Dhabi, UAE).


KSoLa-IAS Joint Session on "Lipoprotein(a), a Crucial but Forgotten Risk Factor for Cardiovascular Disease" (Seoul, Korea, September 6, 2019) held during the 8th International congress on Lipid & Atherosclerosis (ICoLA)
View the Slide Library



The IAS is happy to annouce that the 2019 HDL Workshop held in Valencia, Spain on 25-27th September, 2019 has been extremely successful.
View Final Program of the Workshop.



            IAS NEW ACTIVITIES         

We are pleased to annouce that the International Atherosclerosis Society is launching the 2nd Wael Al-Mahmeed & IAS Research Training Grants and Fellowshps for the MENA Region project. The entire IAS Board is honored and grateful to annouce the this high-level initiative has been made possible by a enerous donation from Dr. Wael Abdulrahman Al Mahmeed (Abu Dhabi, UAE). the Wael Al-Mahmeed & IAS Research Training Grants and Fellowship for the MENA Region is a competitive research funding opportunity aimed at advancing clinical and basic research in atherosclerosis an related cardio-metabolic-cerebrovascular diseases in the MENA Region, as well as promoting partnerships among researacher from recognized MENA Universities and healthcare institutions.
The Wael Al-Mahmeed & IAS Research Training Grants and Fellowships for the MENA Region will award up to three $10,000 grants for a maximum period of 6 months. The final granted amount will be calculated pro rata, according to the length of the cerifiied training period or the duration of the research. For further information about the application on line please contact IAS at info@athero.org. 



7th IAS-Weill Cornell Seminar on Lipid Metabolism and Cardiovascular Risk, Salzburg, Austria, November 3-9, 2019.

The residential Seminar is directed to physicians practicing in Central and Eastern Europe, Central Asia, the former Soviet Union and other countries in transition. The Seminar is organized jointly by the IAS, Weill Cornel Medical College, and the American Austrian Foundation. For further information please link to http://www.aaf-online.org/


The International Atherosclerosis Society (IAS) and the Oman Society of Lipid & Atherosclerosis (OSLA) will organize the 6th IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk to be held in Muscat (Oman) on February 14-17,  2020.
As in 2015, 2016, 2017, 2018 and 2019, the aim of this Course is to increase the knowledge and experience of early- to mid-career, English-speaking practicing clinicians interested in the management of lipid disorders and will be restricted to 30 clinicians from the Middle East and North Africa (MENA) region who manage patients with lipid disorders.
If you are interested in participating, you must apply before December 6th, 2019. Notifications will be sent by December 13, 2019.
Please send your application to: oslaoman@gmail.com 
For more information please click here

In the News:

Also included in this Newsletter:

   XIX International Symposium on Atherosclerosis 2021  


Featured Commentaries
Impaired HDL-mediated macrophage cholesterol efflux in patients with abdominal aortic aneurysm
By: Diego Martínez-López, PhD , Jose Luis Martín-Ventura, PhD , Joan Carles Escolà-Gil, PhD

Human high-density lipoproteins (HDL) include a highly complex and heterogeneous array of lipoprotein subpopulations that are continuously remodeled in the plasma.1 Macrophage ATP-binding cassette (ABC) A1 promotes cholesterol efflux from macrophages to lipid-poor nascent preβ-HDL particles and small HDL, whereas ABCG1 mainly stimulates cholesterol efflux to large and mature HDL particles. This ability of HDL particles to promote macrophage cholesterol efflux is considered the main cardioprotective function associated with HDL. Therefore, the stimulation of the ABCA1-dependent cholesterol efflux from J774.A1 macrophage cells to HDL, but not HDL cholesterol levels, was found to be inversely associated with the incidence of atherothrombotic cardiovascular disease events.  For this reason, current research is focused on improving HDL function rather than simply targeting to increase HDL-cholesterol.

View Complete Commentary
 Upcoming Meetings

September 11-13, 2019

25th  Annual Meeting of the Egyptian association of Endocrinology, Diabetes, and Atherosclerosis (EAEDA)
Alexandria, Egypt

View Final Program

September 20-22, 2019

APSDAV 2019 Congress
Taipei, Taiwan

View Congress information

October 3-4, 2019

International Symposium on Medicine of the
Silk Road
Bishkek, Kyrgyzstan

View Program

October 10-13, 2019

The 30th Great Wall International Congress of Cardiology
Beijing, China
View Congress Information

November 29-30, 2019

8th Panhellenic Congress of the Working Groups
Athens, Greece
View Program

August-December, 2019
Online Course on "Update in Nutrition"
Chilean Working Group on Atherosclerosis

December 1-2, 2019

Statement on Residual Risk with the Interamerican Society of Cardiology
Lima, Peru

For a complete listing of all Member Society Meetings and educational activities

Please click Here

The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission: Aegerion Pharmaceuticals, Akcea Therapeutics Inc., Amarin Pharma Inc - Biologix, Amgen, Inc., Amgen (Europe) GmbH, Amgen Inc, Amryt, Daiichi Sankyo Co., Ltd., Esperion Therapeutics Inc, Fondazione Giovanni Lorenzini, Kaneka Europe, Kowa Company, Ltd., Ono Pharmaceutical Co., Ltd., OSLA - Oman Society of Lipids and Atherosclerosis, Otsuka Pharmaceutical Co., Ltd., Pfizer, Sanofi and Regeneron, The Medicines Company (TMC) and Weill Cornell Medical College.
>> Back To Top <<
IAS Newsletter Editors
Website Editorial Board
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta, PhD
Milan, Italy

Emanuela Folco, PhD
Milan, Italy

Website & Newsletter Editors
Elena Colombo
Milan, Italy
Yelonda Williams, BA
Dallas, TX, USA

 Executive Director

Emanuela Folco, Ph.D.
International Atherosclerosis Society
Viale Piave 35 
20129 Milan, Italy 
Tel: +39 02 29006267
Fax: +39 02 29007018
E-mail: emanuela.folco@athero.org; info@athero.org

US Office:
International Atherosclerosis Society 
C/O SobelCo
50 Tice Boulevard, Suite 175
Woodcliff Lake, NJ 07677, USA
E-mail: info@athero.org

You are a valued member of the International Atherosclerosis Society. You are receiving this email because you opted in at our website - www.athero.org

Unsubscribe <<Email Address>> from this list.

Our mailing address is:
International Atherosclerosis Society
Fondazione Giovanni Lorenzini Medical Science Foundation
viale Piave 35
Milan, Italy 20129

Add us to your address book

Copyright (C) 2019 International Atherosclerosis Society All rights reserved.

Forward this email to a friend
Update your profile